- New nationwide laboratory testing in 2017 uncovered more than 220 instances of germs with “unusual” antibiotic resistance genes, according to the latest Vital Signs report.
- Increased detection and early, aggressive response at the first sign of unusual resistance could prevent an estimated 1,600 cases of carbapenam-resistant Enterobacteriaceae in one state over three years.
- Health departments can work with healthcare facilities and laboratories to implement an aggressive containment strategy and be ready to respond rapidly when unusual resistance strikes.
Interested in learning more? Join us for a Vital Signs Town Hall Teleconference on Tuesday, April 10, 2018, at 2–3 pm (EDT).